Cargando…
Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
Autores principales: | Stefanou, Dimitra T., Bamias, Aristotelis, Episkopou, Hara, Kyrtopoulos, Soterios A., Likka, Maria, Kalampokas, Theodore, Photiou, Stylianos, Gavalas, Nikos, Sfikakis, Petros P., Dimopoulos, Meletios A., Souliotis, Vassilis L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341518/ https://www.ncbi.nlm.nih.gov/pubmed/34352021 http://dx.doi.org/10.1371/journal.pone.0256051 |
Ejemplares similares
-
Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
por: Stefanou, Dimitra T., et al.
Publicado: (2015) -
DNA Damage Repair: Predictor of Platinum Efficacy in Ovarian Cancer?
por: Stefanou, Dimitra T., et al.
Publicado: (2021) -
Immune Response in Ovarian Cancer: How Is the Immune System Involved in Prognosis and Therapy: Potential for Treatment Utilization
por: Gavalas, Nikos G., et al.
Publicado: (2010) -
Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma
por: Gkotzamanidou, M, et al.
Publicado: (2014) -
Correction: Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma
por: Gkotzamanidou, M., et al.
Publicado: (2020)